Clinical Trials Directory

Trials / Unknown

UnknownNCT05351515

Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient Elastography

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are both common diseases related to metabolic diseases with potential cardiovascular consequences and liver complications respectively. Though studies show OSA may take part in the progression of hepatic steatosis, the independent contribution of OSA on liver fat accumulation is unknown. It is hypothesized that nocturnal intermittent hypoxia from OSA is the main driver of NAFLD in non-obese OSA patients. This study is to assess the effect of OSA on NAFLD in non-obese patients.

Conditions

Timeline

Start date
2022-04-30
Primary completion
2025-01-31
Completion
2025-01-31
First posted
2022-04-28
Last updated
2023-08-30

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05351515. Inclusion in this directory is not an endorsement.